Brand Name: Dacikast
Generic Name: Daclatasvir
Manufacturer: Aprazer
Dosage Form: Tablet
Strength: 60mg
Composition: Daclatasvir
Packaging: 28 tablets per bottle
Indication: Hepatitis C
Storage: Store at room temperature
Overview
Dacikast (Daclatasvir) tablet is a prescribed antiviral medicine that helps in lowering the amount of Hepatitis C virus in the body. Daclatasvir works by blocking the activities of a special protein non-structural 5A and this helps to decrease the load of the Hepatitis C virus. Do not take this medicine in the wrong way as it may lead to some severe side effects. If you experience any symptoms while receiving this medicine, inform your doctor immediately. It is advisable not to change or stop the dose without taking suggestions from your doctor. Follow your regular dosing schedule and store this medicine at room temperature.
Pharmacodynamics
Daclatasvir is a direct-acting antiviral (DAA) agent that targets the nonstructural protein 5A (NS5A) and causes a decrease in serum HCV RNA levels. It disrupts HCV replication by specifically inhibiting the critical functions of a nonstructural protein 5A (NS5A) protein in the replication complex. After the oral administration, the effect of this medicine can be observed in 2 hours.
Usage
The use of the Dacikast tablet reduces the amount of Hepatitis C virus in the body and helps in improving the immunity of patients. This medicine is also used along with other medications for treating HCV infection. Take this medicine with or without food orally once a day. The recommended dose is decided by a doctor according to your previous medical condition and response to the treatment. Regular monitoring of kidney and liver function is required while having treatment with this medicine. This medication may take some time to show effect. Do not chew or break the tablet and swallow the whole tablet with a glass of water.
Advantages
Dacikast tablet helps in reducing the complications associated with the liver.
The use of this medicine helps to improve the quality of life of patients.
Daclatasvir decreases the possibility of getting liver cancer.
This medication helps in recurrent HCV infection after the liver transplant operation.
Interactions
Interactions may change how your medication works and increase the risk for side effects. Don’t forget to disclose your previous medical history with the doctor.
Medicine Interactions
Apalutamide
Clarithromycin
Carbamazepine
Modafinil
Primidone
Ketoconazole
Bosentan
Disease Interaction: In patients coinfected with hepatitis B and hepatitis C virus, the use of this medicine may cause a reactivation of HBV.
Alcohol Interaction: Interaction with alcohol is unknown. Please consult your doctor before consuming alcohol.
Contraindication
This medicine is not recommended in patients receiving strong CYP3A inducers.
Do not take this medicine if you are allergic to Daclatasvir.
This medicine is not recommended in patients known to be hypersensitive.


